Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 12
2016 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience.
England A, Wade K, Smith PB, Berezny K, Laughon M; Best Pharmaceuticals for Children Act — Pediatric Trials Network Administrative Core Committee. England A, et al. Contemp Clin Trials. 2016 Mar;47:376-82. doi: 10.1016/j.cct.2016.03.002. Epub 2016 Mar 9. Contemp Clin Trials. 2016. PMID: 26968616 Free PMC article.
Performing drug trials in pediatrics is challenging. In support of the Best Pharmaceuticals for Children Act, the Eunice Kennedy Shriver National Institute of Child Health and Human Development funded the formation of the Pediatric Trials Network (PTN) in 2010. ...
Performing drug trials in pediatrics is challenging. In support of the Best Pharmaceuticals for Children Act, the Eunice Kennedy Shri …
Drug Dosing and Pharmacokinetics in Children With Obesity: A Systematic Review.
Harskamp-van Ginkel MW, Hill KD, Becker KC, Testoni D, Cohen-Wolkowiez M, Gonzalez D, Barrett JS, Benjamin DK Jr, Siegel DA, Banks P, Watt KM; Best Pharmaceuticals for Children Act–Pediatric Trials Network Administrative Core Committee. Harskamp-van Ginkel MW, et al. JAMA Pediatr. 2015 Jul;169(7):678-85. doi: 10.1001/jamapediatrics.2015.132. JAMA Pediatr. 2015. PMID: 25961828 Free PMC article. Review.
Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia.
Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA; Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee. Estepp JH, et al. J Clin Pharmacol. 2016 Mar;56(3):298-306. doi: 10.1002/jcph.598. Epub 2015 Oct 15. J Clin Pharmacol. 2016. PMID: 26201504 Free PMC article. Clinical Trial.
Safety of octreotide in hospitalized infants.
Testoni D, Hornik CP, Neely ML, Yang Q, McMahon AW, Clark RH, Smith PB; Best Pharmaceuticals for Children Act — Pediatric Trials Network Administrative Core Committee. Testoni D, et al. Early Hum Dev. 2015 Jul;91(7):387-92. doi: 10.1016/j.earlhumdev.2015.04.008. Epub 2015 May 15. Early Hum Dev. 2015. PMID: 25968047 Free PMC article.
Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots.
Gonzalez D, Melloni C, Poindexter BB, Yogev R, Atz AM, Sullivan JE, Mendley SR, Delmore P, Delinsky A, Zimmerman K, Lewandowski A, Harper B, Lewis KC, Benjamin DK Jr, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act--Pediatric Trials Network Administrative Core Committee. Gonzalez D, et al. Bioanalysis. 2015;7(9):1137-49. doi: 10.4155/bio.15.38. Bioanalysis. 2015. PMID: 26039810 Free PMC article.
Rifampin use and safety in hospitalized infants.
Arnold CJ, Ericson J, Kohman J, Corey KL, Oh M, Onabanjo J, Hornik CP, Clark RH, Benjamin DK Jr, Smith PB, Chu VH; Best Pharmaceuticals for Children Act–Pediatric Trials Network Administrative Core Committee. Arnold CJ, et al. Am J Perinatol. 2015 May;32(6):565-70. doi: 10.1055/s-0034-1543955. Epub 2015 Jan 16. Am J Perinatol. 2015. PMID: 25594217 Free PMC article.
Cefepime and Ceftazidime Safety in Hospitalized Infants.
Arnold CJ, Ericson J, Cho N, Tian J, Wilson S, Chu VH, Hornik CP, Clark RH, Benjamin DK Jr, Smith PB; Best Pharmaceuticals for Children Act--Pediatric Trials Network Administrative Core Committee. Arnold CJ, et al. Pediatr Infect Dis J. 2015 Sep;34(9):964-8. doi: 10.1097/INF.0000000000000778. Pediatr Infect Dis J. 2015. PMID: 26376308 Free PMC article.
Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection.
Trachtman H, Frymoyer A, Lewandowski A, Greenbaum LA, Feig DI, Gipson DS, Warady BA, Goebel JW, Schwartz GJ, Lewis K, Anand R, Patel UD; Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee. Trachtman H, et al. Clin Pharmacol Ther. 2015 Jul;98(1):25-33. doi: 10.1002/cpt.127. Epub 2015 May 2. Clin Pharmacol Ther. 2015. PMID: 25807932 Free PMC article. Clinical Trial.
Safety of milrinone use in neonatal intensive care units.
Samiee-Zafarghandy S, Raman SR, van den Anker JN, McHutchison K, Hornik CP, Clark RH, Brian Smith P; Best Pharmaceuticals for Children Act—Pediatric Trials Network Administrative Core Committee. Samiee-Zafarghandy S, et al. Early Hum Dev. 2015 Jan;91(1):31-5. doi: 10.1016/j.earlhumdev.2014.10.007. Epub 2014 Nov 26. Early Hum Dev. 2015. PMID: 25460254 Free PMC article.
14 results